Philadelphia, United States
Carenostics, founded in 2021, is a dynamic player in the intersection of AI, Biotechnology, and Health Care. The company is headquartered in the United States and is dedicated to overcoming the challenges of underdiagnosis, undertreatment, and health inequities in chronic disease through advanced AI and ML technologies.
Carenostics develops AI solutions aimed at facilitating earlier clinical intervention for chronic diseases. By integrating machine learning models with existing provider EHRs, the company aids physicians in identifying undiagnosed chronic diseases, monitoring patient decline, and aligning treatment with evidence-based guidelines. Their flagship product, CKDx, targets the eradication of undiagnosed chronic kidney disease while addressing disparities affecting minority populations.
In their latest funding milestone, Carenostics secured a $5.00M Seed Round on September 13, 2023, supported by notable investors including Gaingels, GreatPoint Ventures, M13, and Kurt Hilzinger.
